HOME >> BIOLOGY >> NEWS
Improving livestock health, trade and human livelihoods in Africa

Boston -- In many parts of Africa, livestock are not only a source of food, but also an underutilized trading commodity. Working with international and regional agencies, Africa-based researchers from Feinstein International Center (FIC) at Tufts University address policies and practices to improve animal health and trade in local communities, including constraints around the export of livestock and livestock products. Andrew Catley, PhD, a research director at FIC, contributed to a "Viewpoint" article in the July 8th issue of The Veterinary Record that highlights the need for a trustworthy and viable process to certify the status of livestock commodities as a means to encourage safe export trade. An earlier paper by Catley and colleagues addresses the underlying issue of improving health care services for livestock, a challenge in parts of Africa where a dearth of veterinary services hinders efforts.

"Increasing international trade of livestock is a potentially useful poverty reduction strategy for developing regions, particularly Africa, but there are many obstacles that hinder that trade," says Catley. The authors of the Veterinary Record Viewpoint, including lead author G.R. Thomson, emphasize the need for an independent source of certification based on improved international standards to benefit livestock farmers in Africa.

"Under the current World Trade Organization standards that govern international trade of animals and animal products, trade from developing regions to countries like the United States and European nations is hindered because of concerns about government veterinary services in developing countries. These services are often weak and in some countries, are affected by high levels of corruption, yet they're responsible for issuing international health certificates for livestock exports," explains Catley. Importing countries "need verification that there is minimal risk of infectious disease agents that threaten human healt
'"/>

Contact: Siobhan Gallagher
617-636-6586
Tufts University
26-Jul-2006


Page: 1 2 3

Related biology news :

1. Improving plants abilities to cope with saline conditions
2. Spotlight on liver disease: Improving todays treatments
3. Health care reimagined: Improving patient care through early health
4. Improving outcomes in premature births
5. Improving urban environments: why childrens voices should be heard
6. Improving police cars, recovering lost manuscripts: UH research day delivers
7. Improving the potential of cancer vaccines
8. Improving artificial heart top goal of award-winning research at UH
9. AAAS panel will focus on the impact of livestock production on the planet
10. Killing wolves may not protect livestock efficiently
11. Chemical Society Boston meeting, Aug. 19-23, focuses on health, wellness, energy, environment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... PARSIPPANY, N.J. , Jan. 20, 2017 /PRNewswire/ ... the "Company"), a company that provides clinically useful ... that it has entered into a securities purchase ... aggregate of 855,000 shares of common stock in ... placement, the Company has agreed to sell to ...
(Date:1/21/2017)... 20, 2017 Aratana Therapeutics, Inc. (NASDAQ: ... the licensing, development and commercialization of innovative biopharmaceutical products ... Company in North America 2016. ... based on the FDA approval of three innovative ... ® (capromorelin oral solution) and NOCITA ® ...
(Date:1/20/2017)... ... 2017 , ... The two newest companies to join the University City Science ... out from The Wistar Institute, and Sanguis, launched by a trio of students from ... , Vironika is developing a treatment for a chronic viral infection and its associated ...
(Date:1/20/2017)... 20, 2017 Ginkgo Bioworks, the organism ... pioneer in the synthesis and assembly of DNA. ... assembling pathway-length synthetic DNA into Ginkgo,s automated organism ... the construction of new organism designs for application ... "Gen9 was founded to significantly increase the world,s ...
Breaking Biology Technology:
Cached News: